Results 91 to 100 of about 18,836 (198)

Posaconazole conformation.

open access: yes, 2013
A. Fragments of the Fo-Fc electron density map (grey mesh) in chains A, B and D calculated with the posaconazole coordinates omitted from the input file. B, C.
Matthew P. Jacobson (174588)   +5 more
core   +1 more source

Prediction of Tacrolimus–Posaconazole Interactions in Renal Transplant Patients with Different CYP3A5 Genotypes, Based on Physiological Pharmacokinetic Models

open access: yesPharmaceutics
Objective: Posaconazole, a second-generation triazole antifungal used for the prevention or treatment of invasive fungal infections, has been shown to markedly increase tacrolimus exposure in vivo when co-administered, potentially leading to clinically ...
Mengmeng Guan   +6 more
doaj   +1 more source

Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2012
INTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.
Amir A Tahami Monfared   +3 more
doaj   +1 more source

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial [PDF]

open access: yes, 2017
BACKGROUND Benznidazole is recommended for treatment of Chagas infection. Effects of combination therapy with benznidazole and posaconazole have not been tested in Trypanosoma cruzi carriers.
McCarthy, Michael   +95 more
core   +1 more source

Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients

open access: yes, 2017
Posaconazole is a triazole with limited pharmacokinetic information in children. This study assessed the correlation between posaconazole-oral-solution daily dosage/kg/body weight and trough plasma ...
Francesca Carraro   +21 more
core   +1 more source

In Vivo 11β-Hydroxysteroid Dehydrogenase Inhibition in Posaconazole-Induced Hypertension and Hypokalemia [PDF]

open access: yes, 2017
We describe a case of apparent mineralocorticoid excess (AME) secondary to posaconazole therapy and suggest the biochemical mechanism. Clinical and laboratory investigation confirmed 11β-hydroxysteroid dehydrogenase inhibition and withholding therapy led
Diana Chang   +9 more
core   +1 more source

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

open access: yes, 2018
Javier Martínez-Casanova,1 Nuria Carballo,1 Sonia Luque,1 Luisa Sorli,2 Santiago Grau1 1Pharmacy Department, Hospital del Mar, Barcelona, Spain; 2Infectious Diseases Department, Hospital del Mar, Barcelona, Spain Abstract: Azole antifungals have ...
Santiago Grau   +14 more
core   +1 more source

Real-Life Use of Posaconazole in Clinical Practice for Onco-Hematological Children: A National Survey by AIEOP Infectious Diseases Working Group

open access: yesJournal of Fungi
Background: Posaconazole is an antifungal medication used to treat invasive fungal infections (IFI) in pediatric onco-hematological patients. Its approval for pediatric use was recent, and limitations still apply.
Lorenzo Chiusaroli   +25 more
doaj   +1 more source

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

open access: yesCritical Care, 2019
Background The population pharmacokinetics of total and unbound posaconazole following intravenous administration has not yet been described for the critically ill patient population. The aim of this work was, therefore, to describe the total and unbound
Fekade B. Sime   +9 more
doaj   +1 more source

Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole

open access: yes, 2011
Contains fulltext : 96921.pdf (Publisher’s version ) (Open Access)We report the case of a kidney transplant recipient with invasive aspergillosis due to Aspergillus fumigatus resistant to voriconazole and intermediately susceptible to ...
Paul E. Verweij   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy